{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T08:14:31Z","timestamp":1774599271109,"version":"3.50.1"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>The aim of this study was to assess the superiority of sequential administration of fosfomycin and linezolid in combination on the efficacy of <jats:italic>methicillin-resistant Staphylococcus aureus (MRSA)<\/jats:italic>. The antimicrobial activity was assessed using static and dynamic bactericidal assays, along with pharmacokinetics\/pharmacodynamics <jats:italic>in vitro<\/jats:italic> simulation models. Transmission electron microscopy (TEM) was employed to observe ultrastructural changes in <jats:italic>MRSA<\/jats:italic> cell walls following both sequential and concomitant dosing strategies. The results indicated that in the static time-kill assay, at MIC levels (fosfomycin at 4\u20138\u202fmg\/L and linezolid at 2\u20134\u202fmg\/L), the combination effectively inhibited <jats:italic>MRSA<\/jats:italic> growth under both concurrent and sequential administration; however, the sequential dosing regimen exhibited significantly greater bactericidal activity. Similarly, in the dynamic sterilization test conducted at clinically relevant doses (linezolid 600\u202fmg and fosfomycin 2\u202fg), a comparable trend was observed, further supporting the superior efficacy of sequential administration. TEM analysis further revealed that sequential dosing caused more extensive damage to the bacterial cell wall and nucleus compared to concomitant administration. These findings suggest that sequential administration of fosfomycin and linezolid enhances <jats:italic>in vitro<\/jats:italic> efficacy against <jats:italic>MRSA<\/jats:italic> and may provide an improved approach for managing complicated and drug-resistant infections.<\/jats:p>","DOI":"10.3389\/fmicb.2025.1511707","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T07:18:15Z","timestamp":1742195895000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Enhanced efficacy of sequential administration of fosfomycin and linezolid against methicillin-resistant Staphylococcus aureus"],"prefix":"10.3389","volume":"16","author":[{"given":"Zaixing","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Ai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sailan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiabin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e68876","DOI":"10.7554\/eLife.68876","article-title":"High potency of sequential therapy with only \u03b2-lactam antibiotics","volume":"10","author":"Batra","year":"2021","journal-title":"eLife"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1128\/AAC.01194-06","article-title":"Pharmacokinetic\/pharmacodynamic factors influencing emergence of resistance to linezolid in an in vitro model","volume":"51","author":"Boak","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1128\/AAC.01885-13","article-title":"Clinical population pharmacokinetics and toxicodynamics of linezolid","volume":"58","author":"Boak","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"6413982","DOI":"10.1155\/2016\/6413982","article-title":"Efficacy of linezolid and Fosfomycin in catheter-related biofilm infection caused by methicillin-resistant Staphylococcus aureus","volume":"2016","author":"Chai","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.medmal.2013.09.011","article-title":"The ZephyR study: a randomized comparison of linezolid and vancomycin for Mrsa pneumonia","volume":"43","author":"Chavanet","year":"2013","journal-title":"Med. Mal. Infect."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s10096-019-03801-x","article-title":"Role of linezolid combination therapy for serious infections: review of the current evidence","volume":"39","author":"Chen","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"e00605-19","DOI":"10.1128\/AAC.00605-19","article-title":"Reappraisal of linezolid dosing in renal impairment to improve safety","volume":"63","author":"Crass","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1128\/CMR.00081-09","article-title":"Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic","volume":"23","author":"David","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/antibiotics6040024","article-title":"Fosfomycin: Pharmacological, Clinical and Future Perspectives","volume":"6","author":"Dijkmans","year":"2017","journal-title":"Antibiotics (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1128\/CMR.00068-15","article-title":"Fosfomycin","volume":"29","author":"Falagas","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e1002104","DOI":"10.1371\/journal.pbio.1002104","article-title":"Using a sequential regimen to eliminate bacteria at sublethal antibiotic dosages","volume":"13","author":"Fuentes-Hernandez","year":"2015","journal-title":"PLoS Biol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/jac\/48.2.209","article-title":"In vitro activity of fosfomycin in combination with various antistaphylococcal substances","volume":"48","author":"Grif","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.2147\/DDDT.S164515","article-title":"Linezolid: a review of its properties, function, and use in critical care","volume":"12","author":"Hashemian","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.2147\/IDR.S208298","article-title":"Vancomycin-resistant enterococcal infection in a Thai university hospital: clinical characteristics, treatment outcomes, and synergistic effect","volume":"12","author":"Hemapanpairoa","year":"2019","journal-title":"Infect Drug Resist"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1186\/s12879-024-09797-w","article-title":"Unraveling novel mutation patterns and morphological variations in two dalbavancin-resistant Mrsa strains in Austria using whole genome sequencing and transmission electron microscopy","volume":"24","author":"Hotz","year":"2024","journal-title":"BMC Infect. Dis."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jgar.2020.12.009","article-title":"Meta-analysis of vancomycin versus linezolid in pneumonia with proven methicillin-resistant Staphylococcus aureus","volume":"24","author":"Kato","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e00020-18","DOI":"10.1128\/CMR.00020-18","article-title":"Methicillin-resistant Staphylococcus aureus: molecular characterization, evolution, and epidemiology","volume":"31","author":"Lakhundi","year":"2018","journal-title":"Clin. Microbiol. Rev."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e0201721","DOI":"10.1128\/aac.02017-21","article-title":"Proteomic correlates of enhanced Daptomycin activity following \u03b2-lactam preconditioning in Daptomycin-resistant, Methicillin-Resistant Staphylococcus aureus","volume":"66","author":"Lew","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.jmii.2018.12.007","article-title":"Synergistic effect of linezolid with fosfomycin against Staphylococcus aureus in vitro and in an experimental galleria mellonella model","volume":"53","author":"Li","year":"2020","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e0087121","DOI":"10.1128\/Spectrum.00871-21","article-title":"Dose optimization of combined linezolid and Fosfomycin against Enterococcus by using an in vitro pharmacokinetic\/Pharmacodynamic model","volume":"9","author":"Mao","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"106951","DOI":"10.1016\/j.ijantimicag.2023.106951","article-title":"Sequential treatment effects on phage-antibiotic synergistic application against multi-drug-resistant Acinetobacter baumannii","volume":"62","author":"Mukhopadhyay","year":"2023","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1016\/j.clinthera.2009.10.017","article-title":"Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy","volume":"31","author":"Niwa","year":"2009","journal-title":"Clin. Ther."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1146\/annurev-biochem-060614-034516","article-title":"Mechanisms of methicillin resistance in Staphylococcus aureus","volume":"84","author":"Peacock","year":"2015","journal-title":"Annu. Rev. Biochem."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/S0140-6736(15)60733-4","article-title":"Community-acquired pneumonia","volume":"386","author":"Prina","year":"2015","journal-title":"Lancet"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.2147\/IDR.S219117","article-title":"Pharmacodynamics of linezolid-plus-Fosfomycin against vancomycin-susceptible and -resistant enterococci in vitro and in vivo of a galleria mellonella larval infection model","volume":"12","author":"Qi","year":"2019","journal-title":"Infect Drug Resist."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/FTD.0000000000000710","article-title":"Therapeutic drug monitoring can improve linezolid dosing regimens in current clinical practice: a review of linezolid pharmacokinetics and pharmacodynamics","volume":"42","author":"Rao","year":"2020","journal-title":"Ther. Drug Monit."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3390\/pharmaceutics13060833","article-title":"The role of Pk\/Pd analysis in the development and evaluation of antimicrobials","volume":"13","author":"Rodr\u00edguez-Gasc\u00f3n","year":"2021","journal-title":"Pharmaceutics"},{"key":"ref28","first-page":"252","article-title":"In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus","volume":"19","author":"Sahuquillo Arce","year":"2006","journal-title":"Rev. Esp. Quimioter."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1093\/jac\/dkac380","article-title":"In vitro activity of fosfomycin alone and in combination against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolid","volume":"78","author":"Saravolatz","year":"2022","journal-title":"J. Antimicrob. Chemother."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s10156-010-0182-1","article-title":"Risk factors associated with the development of thrombocytopenia in patients who received linezolid therapy","volume":"17","author":"Takahashi","year":"2011","journal-title":"J. Infect. Chemother."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1093\/jac\/dkr535","article-title":"In vitro efficacy of fosfomycin-containing regimens against methicillin-resistant Staphylococcus aureus in biofilms","volume":"67","author":"Tang","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"11387","DOI":"10.3389\/bjbs.2023.11387","article-title":"Antimicrobial Resistance (Amr)","volume":"80","author":"Tang","year":"2023","journal-title":"Br. J. Biomed. Sci."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3390\/antibiotics9080496","article-title":"Synergy of linezolid with several antimicrobial agents against linezolid-methicillin-resistant staphylococcal strains","volume":"9","author":"Valderrama","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"7170","DOI":"10.1128\/AAC.04955-14","article-title":"Exploration of the pharmacokinetic-Pharmacodynamic relationships for Fosfomycin efficacy using an in vitro infection model","volume":"59","author":"Vanscoy","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"779885","DOI":"10.3389\/fmicb.2021.779885","article-title":"Pharmacodynamics of linezolid plus Fosfomycin against vancomycin-resistant Enterococcus faecium in a hollow Fiber infection model","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Microbiol."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"5089","DOI":"10.2147\/IDR.S343200","article-title":"Development and validation of an Hplc-Uv method for quantitation of linezolid: application to resistance study using in vitro Pk\/Pd model","volume":"14","author":"Yang","year":"2021","journal-title":"Infect Drug Resist."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1511707\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T07:18:17Z","timestamp":1742195897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2025.1511707\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":36,"alternative-id":["10.3389\/fmicb.2025.1511707"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2025.1511707","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"article-number":"1511707"}}